This investment corporation will raise funds via a social loan framework. Total borrowings amount to 8.0 billion yen across two items (50 hundred million yen and 30 hundred million yen), long-term, unsecured, and unguaranteed, with repayments planned around 2030. Funds will be allocated to acquire part of the asset trust beneficiary rights and cover related expenses. A third-party evaluation under JC R\u2019s Social Finance Framework (F) has been obtained.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"3455","jir_company_name":"Health Care & Medical Investment Corporation","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-08-26","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/08\/3455-20260826-02.pdf","jir_short_summary":"This investment corporation will raise funds via a social loan framework. Total borrowings amount to 8.0 billion yen across two items (50 hundred million yen and 30 hundred million yen), long-term, unsecured, and unguaranteed, with repayments planned around 2030. Funds will be allocated to acquire part of the asset trust beneficiary rights and cover related expenses. A third-party evaluation under JC R\u2019s Social Finance Framework (F) has been obtained.","jir_summary":"### Overview of Financing\nThis investment corporation will execute borrowings through a social loan under the Social Finance Framework. Borrowing \u2460 is 50 billion yen, Borrowing \u2461 is 30 billion yen, both long-term, unsecured, and unguaranteed, with repayments planned around around 2030. The funds will be allocated for acquiring part of the target asset\u2019s trust beneficiary rights and for related expenses. As an external evaluation, JC R\u2019s Social Finance Framework evaluation (F) has been obtained.\n\n### Financial impact, risks and considerations\nTotal borrowings will increase after the borrowing, with changes in the composition of short-term and long-term borrowings. Repayment terms and interest rates are variable, based on Zengin Association\u2019s TIBOR, with the first interest payment date set for the end of September 2026. There are no changes to the contents of the risk disclosures (e.g., repayment risk) described in the submitted securities report.","jir_financial_highlights":"Borrowings (Borrowing \u2460): 50 \u5104\u5186 (Unknown)\nBorrowings (Borrowing \u2461): 30 \u5104\u5186 (Unknown)\nBorrowings (Short-term): 6 \u5104\u5186 (Increase)\nLong-term borrowings: Increase (\uff0b10,500 \u767e\u4e07\u5186)\nTotal borrowings: \uff0b11,100 \u767e\u4e07\u5186 (Increase)","jir_category":"","jir_hashtags":"#HealthCareAssetManagement","jir_key_figures":"Borrowings\u2460: 50 \u5104\u5186\nBorrowings\u2461: 30 \u5104\u5186\nBorrowings execution date \u2460: 2026\u5e749\u67081\u65e5\nBorrowings execution date \u2461: 2026\u5e749\u670830\u65e5\nIncrease in long-term borrowings: +10,500 \u767e\u4e07\u5186","jir_meta_title":"\u3010Health Care & Medical Investment Corporation\u3011Funding Notice\uff5cSeptember 2026","jir_meta_description":"Health Care & Medical Investment Corporation conducts financing through a social loan. Total borrowings are 8.0 billion yen and 3.1 billion yen, with long-term, unsecured, and unguaranteed terms; repayment plans are for September and July. Funds to be applied to asset acquisition financing.","jir_og_title":"\u3010Health Care & Medical Investment Corporation\u3011Funding Notice","jir_og_description":"Funding conducted via a social loan. Borrowings are 8.0 billion yen and 3.1 billion yen, unsecured and unguaranteed; details on repayment timing and use of funds disclosed.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":17572,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-107393","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n